DK134548B - Analogous process for the preparation of sulfamyl-m-aminobenzoic acids or salts, esters or amides thereof. - Google Patents

Analogous process for the preparation of sulfamyl-m-aminobenzoic acids or salts, esters or amides thereof.

Info

Publication number
DK134548B
DK134548B DK677369AA DK677369A DK134548B DK 134548 B DK134548 B DK 134548B DK 677369A A DK677369A A DK 677369AA DK 677369 A DK677369 A DK 677369A DK 134548 B DK134548 B DK 134548B
Authority
DK
Denmark
Prior art keywords
sulfamyl
amides
esters
salts
preparation
Prior art date
Application number
DK677369AA
Other languages
Danish (da)
Other versions
DK134548C (en
Inventor
Peter Werner Feit
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB38038/69A external-priority patent/GB1249490A/en
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Publication of DK134548B publication Critical patent/DK134548B/en
Application granted granted Critical
Publication of DK134548C publication Critical patent/DK134548C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Pyridine Compounds (AREA)
DK677369AA 1968-12-24 1969-12-22 Analogous process for the preparation of sulfamyl-m-aminobenzoic acids or salts, esters or amides thereof. DK134548B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB38038/69A GB1249490A (en) 1968-12-24 1968-12-24 New sulphamyl-benzoic acid derivatives
GB3089869 1969-06-18
US84593969A 1969-07-24 1969-07-24
GB3803869 1969-07-29

Publications (2)

Publication Number Publication Date
DK134548B true DK134548B (en) 1976-11-29
DK134548C DK134548C (en) 1977-05-02

Family

ID=27448796

Family Applications (1)

Application Number Title Priority Date Filing Date
DK677369AA DK134548B (en) 1968-12-24 1969-12-22 Analogous process for the preparation of sulfamyl-m-aminobenzoic acids or salts, esters or amides thereof.

Country Status (14)

Country Link
JP (2) JPS5420483B1 (en)
BE (1) BE743744A (en)
CH (1) CH532559A (en)
DE (2) DE1964503A1 (en)
DK (1) DK134548B (en)
FI (1) FI51587C (en)
FR (1) FR2027043B1 (en)
IE (1) IE33874B1 (en)
IS (1) IS985B6 (en)
IT (1) IT1143801B (en)
NL (1) NL154727B (en)
NO (1) NO132234C (en)
SE (1) SE380013B (en)
YU (1) YU34983B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3647873A (en) * 1970-02-03 1972-03-07 Merck & Co Inc Nuclear sulfonyl substituted n-acyl-benzenesulfonamides
AR206507A1 (en) * 1972-10-13 1976-07-30 Ciba Geigy Ag PROCEDURE FOR THE OBTAINING OF NEW 4-ETHERS OF 3-AMINO-5-SULFAMOYLBENZOIC ACIDS
DE2419970C3 (en) * 1974-04-25 1980-06-12 Hoechst Ag, 6000 Frankfurt 3- <1-Pyrrolidinyl) -4-phenoxy-5sulfamoylbenzoic acid and process for its preparation
DE2655331A1 (en) * 1976-12-07 1978-06-08 Hoechst Ag PREPARATION FORMS OF 3-N-PYRROLIDINO-4-PHENOXY-5-SULFAMYL-BENZOESIC ACID AND METHOD FOR THE PRODUCTION THEREOF
CA1135705A (en) * 1978-07-20 1982-11-16 Jens-Uwe Bliesener N-arylsulfonylpyrroles, their preparation, and therapeutic agents containing these compounds
DE3941703C2 (en) * 1989-12-18 2002-11-07 Sanol Arznei Schwarz Gmbh Pharmaceutical preparation containing bumetanide

Also Published As

Publication number Publication date
DE1964503A1 (en) 1970-07-09
FI51587B (en) 1976-11-01
JPS5420483B1 (en) 1979-07-23
DE1964504B2 (en) 1977-07-07
IT1143801B (en) 1986-10-22
IE33874L (en) 1970-06-24
NO132234B (en) 1975-06-30
DK134548C (en) 1977-05-02
IS1894A7 (en) 1971-06-25
FI51587C (en) 1977-02-10
IS985B6 (en) 1978-02-22
FR2027043B1 (en) 1978-08-18
SE380013B (en) 1975-10-27
YU319069A (en) 1979-12-31
JPS5024299B1 (en) 1975-08-14
CH532559A (en) 1973-01-15
IE33874B1 (en) 1974-11-27
NL154727B (en) 1977-10-17
DE1964504C3 (en) 1978-03-02
DE1964504A1 (en) 1970-07-09
NO132234C (en) 1975-10-08
YU34983B (en) 1980-06-30
FR2027043A1 (en) 1970-09-25
NL6919391A (en) 1970-06-26
BE743744A (en) 1970-06-24

Similar Documents

Publication Publication Date Title
DK124884B (en) Analogous process for the preparation of 2-bromo-α-ergocryptine or acid addition salts thereof.
DK128005B (en) Analogous process for the preparation of bis-chromones or salts, amides or esters thereof.
DK124129B (en) Analogous process for the preparation of heterocyclic carboxylic acids or salts thereof.
DK136217B (en) Process for the preparation of 7-acylamidocephem-4-carboxylic acids or 6-acylamidopenicillanic acids or salts or esters of such compounds.
DK126788B (en) Analogous process for the preparation of γ-morpholino-p-amino-butyrophenones or salts thereof.
DK129650B (en) Analogous process for the preparation of 1-phenoxy-2-hydroxy-3-amino-propanes or salts thereof.
DK129162B (en) Analogous process for the preparation of 4-oxo-4H-1-benzopyran-2-carboxylic acids or salts, esters or amides thereof.
DK117639B (en) Process for the preparation of substituted phenylacetic acids or salts thereof.
DK128420B (en) Analogous process for the preparation of thiachromone-2-carboxylic acids or their salts with bases.
DK127879B (en) Analogous process for the preparation of 5β-taurocholenic or 5β-taurocholadienoic acids or their salts, esters or amides.
DK138599B (en) Analogous process for the preparation of sulfamylanthranilic acids or their salts or esters.
DK115767B (en) Process for the preparation of 2-phenoxy-2-alkylidene acetic acids or salts thereof.
DK140639B (en) Process for the preparation of 7beta-acylamino-3-methyl-ceph-3-em-4-carboxylic acids or their salts, esters or amides.
DK127644B (en) Analogous process for the preparation of ergopeptins or acid addition salts thereof.
DK123708B (en) Process for the preparation of polyenecarboxylic acids or salts thereof.
DK134548B (en) Analogous process for the preparation of sulfamyl-m-aminobenzoic acids or salts, esters or amides thereof.
DK120159B (en) Analogous process for the preparation of p-alkyloxy, p-alkenyloxy, p-alkynyloxy or p-cycloalkenyloxyphenylacetic acids or salts thereof.
DK120155B (en) Analogous process for the preparation of aminopropiophenones or acid addition salts thereof.
DK137758B (en) Analogous process for the preparation of 2- (5-nitro-2-imidazolyl) -benzimidazoles or salts thereof.
DK125987B (en) Analogous process for the preparation of 4-phenoxy-phenoxyalkanecarboxylic acids or their esters or salts.
DK131149B (en) Analogous process for the preparation of 4-hydroxy-cinnolinecarboxylic acids or salts thereof.
DK125132C (en) Analogous process for the preparation of substituted phenylalkanoic acids or salts thereof.
DK122607B (en) Analogous process for the preparation of heterocyclic carboxylic acids or salts thereof.
DK121086B (en) Analogous process for the preparation of aminoalkanoylbenzofurancarboxylic acids or salts thereof.
DK135572B (en) Process for the preparation of 2- (3-benzoyl-2-hydroxy-phenyl) -alkanoic acids or salts thereof.

Legal Events

Date Code Title Description
PUP Patent expired